Global Biological Dura Patch Market Growth 2025-2031
Description
The global Biological Dura Patch market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The dura mater is a dense, leathery membrane that covers and protects the brain and spinal cord. A dural graft substitute is used when the opening in the dura is too large to be stitched together. Dural replacements are necessary to prevent CSF leakage and to allow the opening of the dura to heal after surgery. Dural substitutes can be biological, harvested from animal or human cadavers, or synthetic, and used as inlays or sutureable grafts. The main benefit of using a dura mater substitute is that it resembles the patient"s dura mater and is able to absorb and integrate itself into the host tissue.
United States market for Biological Dura Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Biological Dura Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Biological Dura Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Biological Dura Patch players cover LeMaitre, Braun, Medtronic, Aesculap, Artimedica, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Biological Dura Patch Industry Forecast” looks at past sales and reviews total world Biological Dura Patch sales in 2024, providing a comprehensive analysis by region and market sector of projected Biological Dura Patch sales for 2025 through 2031. With Biological Dura Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biological Dura Patch industry.
This Insight Report provides a comprehensive analysis of the global Biological Dura Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biological Dura Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biological Dura Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biological Dura Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biological Dura Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Biological Dura Patch market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Biological Graft
Xenograft
Segmentation by Application:
Neurosurgery
Spine Surgery
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
LeMaitre
Braun
Medtronic
Aesculap
Artimedica
W.L.Gore Associates,Inc.
Cerafix
B. Braun
Integra LifeSciences
Linacol Medical
COOK Medical
Vostra
TianXinFu Medical
Bioimplon
Cousin Surgery
Acera Surgical,Inc.
Medprin
Stryker
DePuy Synthes
Gunze Limited
Baxter
Bennett Health,Inc.
RTI Surgical
Natus Medical Incorporated
Beijing Biosis Healing Biological Technology
Guanhao Biotech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Biological Dura Patch market?
What factors are driving Biological Dura Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biological Dura Patch market opportunities vary by end market size?
How does Biological Dura Patch break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The dura mater is a dense, leathery membrane that covers and protects the brain and spinal cord. A dural graft substitute is used when the opening in the dura is too large to be stitched together. Dural replacements are necessary to prevent CSF leakage and to allow the opening of the dura to heal after surgery. Dural substitutes can be biological, harvested from animal or human cadavers, or synthetic, and used as inlays or sutureable grafts. The main benefit of using a dura mater substitute is that it resembles the patient"s dura mater and is able to absorb and integrate itself into the host tissue.
United States market for Biological Dura Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Biological Dura Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Biological Dura Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Biological Dura Patch players cover LeMaitre, Braun, Medtronic, Aesculap, Artimedica, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Biological Dura Patch Industry Forecast” looks at past sales and reviews total world Biological Dura Patch sales in 2024, providing a comprehensive analysis by region and market sector of projected Biological Dura Patch sales for 2025 through 2031. With Biological Dura Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biological Dura Patch industry.
This Insight Report provides a comprehensive analysis of the global Biological Dura Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biological Dura Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biological Dura Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biological Dura Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biological Dura Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Biological Dura Patch market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Biological Graft
Xenograft
Segmentation by Application:
Neurosurgery
Spine Surgery
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
LeMaitre
Braun
Medtronic
Aesculap
Artimedica
W.L.Gore Associates,Inc.
Cerafix
B. Braun
Integra LifeSciences
Linacol Medical
COOK Medical
Vostra
TianXinFu Medical
Bioimplon
Cousin Surgery
Acera Surgical,Inc.
Medprin
Stryker
DePuy Synthes
Gunze Limited
Baxter
Bennett Health,Inc.
RTI Surgical
Natus Medical Incorporated
Beijing Biosis Healing Biological Technology
Guanhao Biotech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Biological Dura Patch market?
What factors are driving Biological Dura Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biological Dura Patch market opportunities vary by end market size?
How does Biological Dura Patch break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
176 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Biological Dura Patch by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Biological Dura Patch by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
